Arthro Therapeutics secured $7.2M in capital investment from Alfvén & Didrikson and existing investors.
Arthro Therapeutics, a Malmö, Sweden-based company providing a software-as-a-medicine for osteoarthritis digital platform, announced in a press release that it secured SEK 65M ($7.2M) in capital investment.
The money was provided by new and existing investors, including Swedish investment company Alfvén & Didriksson, and will be used to to scale up the business to countries outside Sweden.
Arthro Therapeutics, founded in 2014 and led by Jakob Dahlberg, CEO & Co-Founder, developed Joint Academy, a digital health platform connecting osteoarthritis patients with physiotherapists who provide them with individual care and recommend exercises. The platform provides access to digital therapy treatment, allowing physiotherapists to provide more individual care without requiring more of their resources. Joint Academy is used by 100 physiotherapists.
Prior to this capital raise, Arthro Therapeutics secured about $3.2M in funding from investors including Dendera Ventures, Incos Invest, Sweet Capital, Lund University and angel investors Sophia Bendz, Hampus Jakobsson and Tim Jackson.